Anticorps Polyclonal de lapin anti-Laminin beta 1
Laminin beta 1 Polyclonal Antibody for WB, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris et plus (1)
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 23498-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules NIH/3T3, cellules Jurkat |
| Résultats positifs en IP | cellules NIH/3T3, |
| Résultats positifs en IF/ICC | cellules HepG2, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 23 publications below |
| IHC | See 1 publications below |
| IF | See 20 publications below |
Informations sur le produit
23498-1-AP cible Laminin beta 1 dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Réactivité citée | rat, Humain, singe, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | Laminin beta 1 Protéine recombinante Ag19182 |
| Nom complet | laminin, beta 1 |
| Masse moléculaire calculée | 1786 aa, 198 kDa |
| Poids moléculaire observé | 220 kDa |
| Numéro d’acquisition GenBank | BC113455 |
| Symbole du gène | Laminin beta 1 |
| Identification du gène (NCBI) | 3912 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Laminins are a family of basement membrane glycoproteins composed of three nonidentical chains, laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) (PMID: 7959779). Laminins contribute to the structure of extracellular matrix and influence the behavior of associated cells, such as adhesion, differentiation, migration, phenotype stability, and resistance to anoikis (PMID: 23057746). Laminin beta 1 (LAMB1) is expressed in most tissues that produce basement membranes, and is one of the 3 chains constituting laminin-1, the first laminin isolated from Engelbreth-Holm-Swarm (EHS) tumor. Laminin beta 1 is also a subunit of laminin-2 (laminin-211 or merosin), laminin-6 (laminin-311 or K-laminin), laminin-8 (laminin-411), laminin-10 (laminin-511) and laminin-12 (laminin-213).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for Laminin beta 1 antibody 23498-1-AP | Download protocol |
| IF protocol for Laminin beta 1 antibody 23498-1-AP | Download protocol |
| IP protocol for Laminin beta 1 antibody 23498-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Acta Pharm Sin B A novel PGAM5 inhibitor LFHP-1c protects blood-brain barrier integrity in ischemic stroke. | ||
ACS Appl Mater Interfaces Novel Thermosensitive Hydrogel Promotes Spinal Cord Repair by Regulating Mitochondrial Function. | ||
Cell Rep Stub1 maintains proteostasis of master transcription factors in embryonic stem cells. | ||
J Neuroinflammation SU16f inhibits fibrotic scar formation and facilitates axon regeneration and locomotor function recovery after spinal cord injury by blocking the PDGFRβ pathway. | ||
Brain Pathol Reconstituting neurovascular unit with primary neural stem cells and brain microvascular endothelial cells in three-dimensional matrix. | ||
Angiogenesis SNAI1, an endothelial-mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization. |



